Suchergebnisse - "Esaki, Taito"

PubPharm (261)

1

Safety and Efficacy of Encorafenib, Binimetinib, and Cetuximab for BRAFV600E-Mutant Metastatic Colorectal Cancer : Results of the Japanese Expanded Access Program

enthalten in: Clinical colorectal cancer | 2024

von Kotani, D. | Takashima, A. | Kato, T. | +16

2

A phase 2, multicenter, open-label study of anti-LAG-3 ieramilimab in combination with anti-PD-1 spartalizumab in patients with advanced solid malignancies

enthalten in: Oncoimmunology | 2024

von Lin, C. | Garralda, E. | Schöffski, P. | +27

3

Survival in Older Japanese Adults With Advanced Cancer Before and After Implementation of a Geriatric Oncology Service

enthalten in: JCO oncology practice | 2023

von Nishijima, T. | Shimokawa, M. | Komoda, M. | +6

4

Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C

enthalten in: The New England journal of medicine | 2023

von Fakih, M. | Salvatore, L. | Esaki, T. | +16

5

Survival outcomes including salvage therapy of adult head and neck para-meningeal rhabdomyosarcoma : a multicenter retrospective study from Japan

enthalten in: BMC cancer | 2023

von Tsuchihashi, K. | Ito, M. | Arita, S. | +34

6

Identification of an optimal mutant allele frequency to detect activating KRAS, NRAS, and BRAF mutations in a commercial cell-free DNA next-generation sequencing assay in colorectal and pancreatic adenocarcinomas

enthalten in: Journal of gastrointestinal oncology | 2023

von Caughey, B. | Umemoto, K. | Green, M. | +16

7

Survival outcomes including salvage therapy of adult head and neck para-meningeal rhabdomyosarcoma: a multicenter retrospective study from Japan

enthalten in: BMC cancer | 2023

von Tsuchihashi, K. | Ito, M. | Arita, S. | +34

8

Sidedness-Dependent Prognostic Impact of Gene Alterations in Metastatic Colorectal Cancer in the Nationwide Cancer Genome Screening Project in Japan (SCRUM-Japan GI-SCREEN)

enthalten in: Cancers | 2023

von Kajiwara, T. | Nishina, T. | Yamashita, R. | +13

9

Renal impairment as a risk factor for trifluridine/tipiracil-induced adverse events in metastatic colorectal cancer patients from the REGOTAS study

enthalten in: Scientific reports | 2023

von Shiroyama, M. | Fukuoka, S. | Masuishi, T. | +8

10

Mutational spectrum of TP53 gene correlates with nivolumab treatment efficacy in advanced gastric cancer (TP53MUT study)

enthalten in: British journal of cancer | 2023

von Ando, K. | Nakamura, Y. | Kitao, H. | +25

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[27]